Safety and Antiviral Activity of Clevudine in Patients Infected With Hepatitis B Virus

PHASE2TerminatedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 31, 2002

Study Completion Date

March 31, 2004

Conditions
Hepatitis B
Interventions
DRUG

clevudine

Trial Locations (8)

152-703

Korea University Guro Hospital, Guro-dong

110-744

Seoul National University, Yeongeon-dong

134-701

Kangdong Sacred Heart Hospital, Gildong

135-710

Samsung Medical Center, Ilwon-dong

146-92

Yongdong Severance Hospital, Togok-tong

388-1

Asan Medical Center, P’ungnabi-dong

911-1

Ewha Womans University Hospital, Mokdong

150-713

St. Mary's Hospital, Youido

Sponsors
All Listed Sponsors
lead

Bukwang Pharmaceutical

INDUSTRY